neurons

Portable, Electromagnetic RF Imaging Innovations

We aim to change the stroke care paradigm. Rather than taking the patient to the medical imaging technology, we aim to bring the imaging to the patient, saving time to diagnosis, time to treatment and salvaging more of the brain for better patient outcomes.

How it works

EMVision is developing a portable brain scanner for rapid, point of care, Stroke Diagnosis and Monitoring

The EMVT technology relies on the contrast of the dielectric properties between healthy and unhealthy tissue. If a pathology is present, the conductivity and permittivity of that tissue will change.

Learn More

Video file

What's New? Check Our Latest News

Read about our latest company and technology developments and clinical insights

10 August 2021

EMVision unveils 1st Gen

The first generation device has been assembled and is targeted for use in intensive care units, stroke and neurology wards and emergency departments. The device was developed using intellectual proper...
10 August 2021

Ground-breaking stroke technology trialled in Australian hospitals | 7NEWS

Read The Article

10 December 2018

EMvision lists on the ASX

Former Nanosonics chief executive Dr Ron Weinberger has taken on the top job at EMvision Medical Devices, which is using 10 years of research from the University of Queensland, to develop its non-inva...

Read The Article

1st Gen

About Us

EMVision is an Australian medical device company

EMVision has acquired IP from The University of Queensland to develop and commercialize an innovative medical imaging breakthrough. The medical imaging IP is a result of over 10 years of research and development by researchers at the University of Queensland

 

eye icon
Our Vision

We aim to change the Stroke Care paradigm and in doing so positively impact the lives of millions globally.

concentric circles
Our Lead Product in Development

Is a portable, cost-effective, non-ionising and safe brain scanner, capable of rapidly producing quality images of biological tissue to provide game-changing insights for clinicians.